A detailed history of Zevenbergen Capital Investments LLC transactions in Amgen Inc stock. As of the latest transaction made, Zevenbergen Capital Investments LLC holds 9,874 shares of AMGN stock, worth $3.12 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
9,874
Previous 9,399 5.05%
Holding current value
$3.12 Million
Previous $2.67 Million 15.46%
% of portfolio
0.07%
Previous 0.06%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$262.75 - $319.31 $124,806 - $151,672
475 Added 5.05%
9,874 $3.09 Million
Q1 2024

May 07, 2024

BUY
$268.87 - $324.56 $6,721 - $8,114
25 Added 0.27%
9,399 $2.67 Million
Q4 2023

Feb 08, 2024

BUY
$255.7 - $288.46 $324,739 - $366,344
1,270 Added 15.67%
9,374 $2.7 Million
Q2 2023

Aug 09, 2023

BUY
$214.27 - $253.37 $10,713 - $12,668
50 Added 0.62%
8,104 $1.8 Million
Q1 2023

May 11, 2023

BUY
$225.79 - $275.2 $5,644 - $6,880
25 Added 0.31%
8,054 $1.95 Million
Q4 2022

Feb 13, 2023

BUY
$229.03 - $291.01 $73,289 - $93,123
320 Added 4.15%
8,029 $2.11 Million
Q3 2022

Nov 14, 2022

BUY
$224.46 - $253.15 $23,568 - $26,580
105 Added 1.38%
7,709 $1.74 Million
Q1 2022

May 12, 2022

BUY
$219.27 - $242.57 $133,754 - $147,967
610 Added 8.72%
7,604 $1.84 Million
Q4 2021

Feb 11, 2022

SELL
$198.88 - $227.6 $88,501 - $101,282
-445 Reduced 5.98%
6,994 $1.57 Million
Q3 2021

Nov 12, 2021

SELL
$212.27 - $248.7 $5,306 - $6,217
-25 Reduced 0.33%
7,439 $1.58 Million
Q2 2021

Aug 11, 2021

BUY
$233.58 - $259.14 $167,009 - $185,285
715 Added 10.59%
7,464 $1.82 Million
Q1 2021

May 12, 2021

BUY
$221.91 - $258.6 $27,738 - $32,325
125 Added 1.89%
6,749 $1.68 Million
Q4 2020

Feb 10, 2021

BUY
$216.38 - $257.67 $360,272 - $429,020
1,665 Added 33.58%
6,624 $1.52 Million
Q3 2020

Nov 12, 2020

BUY
$234.65 - $260.95 $184,200 - $204,845
785 Added 18.81%
4,959 $1.26 Million
Q2 2020

Aug 12, 2020

BUY
$197.81 - $242.74 $122,246 - $150,013
618 Added 17.38%
4,174 $984,000
Q1 2020

May 12, 2020

BUY
$182.24 - $241.7 $116,633 - $154,688
640 Added 21.95%
3,556 $721,000
Q4 2019

Feb 07, 2020

SELL
$189.21 - $243.2 $1,324 - $1,702
-7 Reduced 0.24%
2,916 $703,000
Q3 2019

Nov 08, 2019

BUY
$174.11 - $208.62 $98,023 - $117,453
563 Added 23.86%
2,923 $566,000
Q2 2019

Aug 13, 2019

SELL
$166.7 - $195.41 $51,510 - $60,381
-309 Reduced 11.58%
2,360 $435,000
Q1 2019

May 14, 2019

BUY
$180.87 - $203.88 $1,627 - $1,834
9 Added 0.34%
2,669 $507,000
Q4 2018

Feb 14, 2019

BUY
$178.4 - $208.25 $16,948 - $19,783
95 Added 3.7%
2,660 $518,000
Q3 2018

Nov 13, 2018

BUY
$185.29 - $208.89 $19,455 - $21,933
105 Added 4.27%
2,565 $532,000
Q2 2018

Aug 14, 2018

SELL
$166.05 - $186.51 $17,435 - $19,583
-105 Reduced 4.09%
2,460 $454,000
Q1 2018

May 15, 2018

SELL
$169.43 - $198.0 $38,121 - $44,550
-225 Reduced 8.06%
2,565 $437,000
Q4 2017

Feb 14, 2018

BUY
$168.79 - $188.59 $15,191 - $16,973
90 Added 3.33%
2,790 $485,000
Q3 2017

Nov 09, 2017

BUY
$167.29 - $191.0 $451,683 - $515,700
2,700
2,700 $503,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Zevenbergen Capital Investments LLC Portfolio

Follow Zevenbergen Capital Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zevenbergen Capital Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Zevenbergen Capital Investments LLC with notifications on news.